AstraZeneca Shares Dual Oncology Clinical and Regulatory Victories
SLS Stock Rises Overnight: Healthcare Execs Tout AML Drug As ‘Game Changer’ Ahead Of Final Trial Trigger
IONS, AZN Stocks Fall On Full Data From Failed Cardiomyopathy Trial — Jefferies Sees Neutral To Negative Readthrough To ALNY
AstraZeneca (LSE:AZN) Reports Positive TEZSPIRE Phase 3 Results, Is The Discount Too Wide?
What Is AstraZeneca (LSE:AZN) Signaling With Its Latest Late Stage Trial Results?
Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent?
AstraZeneca Stock Remains 14% Lower Despite Tezspire Phase 3 Success
New data could widen use of AstraZeneca, Amgen immune disease drug
Amgen-AstraZeneca’s Tezspire nets another Phase III inflammatory disease win
TEZSPIRE demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
AstraZeneca, Amgen Score Phase 3 Win in Debilitating Swallowing Disease
AstraZeneca, Amgen Report Phase III Results For TEZSPIRE In Eosinophilic Esophagitis; TEZSPIRE Meets Key Endpoints In Phase III CROSSING Trial
Amgen And AstraZeneca's TEZSPIRE Meets Both Co-Primary And All Key Secondary Endpoints In Phase 3 CROSSING Trial For Eosinophilic Esophagitis
AstraZeneca And Daiichi Sankyo Dose First Patient In Phase 3 TROPION-Urothelial04 Trial Of Datroway In Muscle-Invasive Urothelial Cancer
AstraZeneca And Daiichi Sankyo Report DESTINY‑Lung04 Phase III Trial Results; ENHERTU Improves Progression‑Free Survival Versus Standard Of Care In HER2‑Mutant NSCLC
AstraZeneca And HUTCHMED’s Savolitinib, In Combination With TAGRISSO, Delivers Significant Survival Benefits In SAFFRON Phase III EGFRm Lung Cancer Trial
AstraZeneca PLC (AZN) Q2 2026 Earnings Call Transcript
AstraZeneca: Q2 2026 Results Were All Right, But Farxiga Poses Risks
Pipeline Speed Bump Doesn't Shake AstraZeneca's $80 Billion Revenue Ambition
AstraZeneca Announces That Results From Its CLARITY-Gastric01 Global Phase III Trial Showed That Sonesitatug Vedotin Demonstrated Statistically Significant And Highly Clinically Meaningful Improvement In Overall Survival
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.